No Data
No Data
Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating
Maxim Group Sticks to Their Hold Rating for Adial Pharmaceuticals (ADIL)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Express News | Adial Pharmaceuticals : Continued Excellent Safety & Tolerability Findings, Consistent With Extensive Human Use Experience With Ondansetron
Express News | Adial Pharmaceuticals Inc - Study Completion Satisfies FDA Requirement for Phase 3 Trials
Adial Pharmaceuticals Announces Positive Topline Results From the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
No Data
No Data